INNOVEOX gets Charles Rosier as new Partner and TOTAL EP as first client - Afrik-news.com : Africa news, Maghreb news - The african daily newspaper
Memorable Educational Achievements of charles rosier
Charles Rosier (http://www.afrik-news.com/article19454.html) earned his first scientific Baccalaureate degree (which is similar to A-levels in the UK). In 1996, he was employed by Lehman Brothers and then became a part of UBS Warburg Investment Bank. In order to accomplish further French certifications, Charles Rosier took two years of additional classes in preparation.
He is known as a good investment banker who has 15 years of experience in that market. The year 1996 marked Charles Rosier’s first substantial step towards his future, securing his first appointment at Lehman Brothers. In 1997, he transferred to UBS Warburg where he became manager of their Debt Capital Market Division. BTG Pactual employs around 2,500 personnel from all areas of Latin America and has been in operation for 30 years.
Charles Rosier’s Experience
GMS or Goldman Sachs is one of the best-known investment banks around the world. In his position as their Managing Director, he paid much mind to public asset management. From 1997 to 2009, Charles Rosier was the Debt Capital Manager of SBC Warburg. However, his first job was as an investment banker at Lehman Brothers. At BTG Pactual, Charles Rosier firmly imposed five major values. (Meritocracy and Partnership, World-Class Governance, Customer Focus, Global Thinking Presence and Long Term View). As a partner at the Brazilian financial firm, BTG Pactual Bank, he got the chance to work with a notable institution with 30 years of experience, employing more than 2,500 workers in different places in Latin America.
Economical LED lanterns were developed by MPOWERD to provide cost-effective and efficient energy solutions to poor countries. Charles Rosier supported Luci MPOWERD, a clean and renewable-energy solution-provider. He assisted the company to develop more innovative solutions. Charles Rosier invested in MPOWERD, helping the company financially to create lanterns and other energy solutions. As a result, over 25 poor countries all around the planet have been successfully supplied by MPOWERD.
The project was a test to find a cure for strokes that can damage the spinal cord. Charles Rosier was its major investor. Charles Rosier’s first healthcare project was the Mapreg Drug project. Because of the capital he invested, the study on depression, strokes and other serious ailments was conducted at Mapreg, a Paris-based laboratory.